July’s designation as UV Safety Month comes as no surprise. July is the month of summer vacations, beach trips, and plenty of other outdoor activities. Because I have a family history of skin cancer, UV Safety Month holds a unique and important personal importance. When I was asked to author an article for the July issue of ICD-10monitor, skin cancer coding struck me as the perfect topic.
Did You Know?
Skin cancer rates are on the rise. In fact, skin cancer has become the most frequently diagnosed form of cancer in the U.S., according to the American Cancer Society. The Skin Cancer Foundation notes that every year there are “more new cases of skin cancer than the combined incidence of cancers of the breast, prostate, lung and colon.”
Several factors are contributing to the rise in skin cancer diagnoses nationwide:
While basal cell and squamous cell carcinomas are the most common forms of skin cancer, melanomas are the most deadly, with an estimated 10,000 Americans dying from melanoma in 2017. According to the Skin Cancer Foundation, an estimated 87,110 new cases of invasive melanoma will be diagnosed in the U.S. in 2017. Melanoma can be caused by too much exposure to ultraviolet (UV) rays from the sun or other sources, such as tanning beds and sun lamps.
Successful prevention measures include being aware of the UV index, early detection, and reducing UV exposure. During UV Safety Month, it is important to note the following UV index levels and associated protection recommendations:
| UV Index | Recommended Protection |
| Extremely High (11+) | Sunscreen, sunglasses, hat, shade, indoors from 10 a.m. until 4 p.m. |
| Very High (7-10) | Sunscreen, sunglasses, hat, shade |
| High (6-7) | Sunscreen, sunglasses, hat, shade |
| Medium (3-5) | Sunscreen, sunglasses, hat |
| Low (0-2) | Sunscreen, sunglasses |
Breaking Down the Diagnosis: Cell Type Matters
Clinical coding of skin cancers is based on two key factors: the type of cell involved and anatomical site. As mentioned above, basal and squamous cell are the most common types. These types of skin cancers are usually treated topically in the physician’s office and require minimal coding expertise. However, melanoma is more invasive, and treatment typically includes a hospital encounter with radical wide excision, skin grafts, and lymph node excision.
Coding Melanomas: Definitions and Staging
In ICD-10-CM, melanoma is differentiated as melanoma or melanoma in situ. Melanoma is reported with codes from category C43, while melanoma in situ is reported with codes in category D03. To better understand the ICD-10-CM classification of these two conditions, the coder first must understand the definitions of these terms and how melanomas are staged.
Melanoma in situ has invaded the epidermis layer only, and is described as Stage 0. However, malignant melanoma is a malignant neoplasm that has invaded the dermis and is described as Stage I through IV, depending on several factors:
Stage I
Stage IA: The melanoma is less than 1.0 mm in thickness. It is not ulcerated and has not been found in lymph nodes or distant organs.
Stage IB: The melanoma is less than 1.0 mm in thickness and is ulcerated, OR it is between 1.01 and 2.0 mm and is not ulcerated. It has not been found in lymph nodes or distant organs.
Stage II
Stage IIA: The melanoma is between 1.01 mm and 2.0 mm in thickness and is ulcerated, OR it is between 2.01 and 4.0 mm and is not ulcerated. It has not been found in lymph nodes or distant organs.
Stage IIB: The melanoma is between 2.01 mm and 4.0 mm in thickness and is ulcerated, OR it is thicker than 4.0 mm and is not ulcerated. It has not been found in lymph nodes or distant organs.
Stage IIC: The melanoma is thicker than 4.0 mm and is ulcerated. It has not been found in lymph nodes or distant organs.
Stage III
Stage IIIA: The melanoma can be of any thickness, but it is not ulcerated. It has spread to one to three lymph nodes near the affected skin area, but the nodes are not enlarged and the melanoma is found only when they are viewed under the microscope. There is no distant spread.
Stage IIIB: One of the following applies:
Stage IIIC: One of the following applies:
Stage IV
The melanoma has spread beyond the original area of skin and nearby lymph nodes to other organs such as the lung, liver, brain, or distant areas of the skin, subcutaneous tissue, or distant lymph nodes. Neither spread to nearby lymph nodes, and thickness is not considered in this stage, but typically the melanoma is thick and has also spread to the lymph nodes. For example, former President Carter’s melanoma was classified as Stage IV since it metastasized to his brain and liver.
In ICD-10-CM, documentation is required specifying whether the melanoma is in situ (which is captured with ICD-10-CM code D03, Melanoma in situ) or if the melanoma has invaded the dermis (which is captured with ICD-10-CM code C43, Malignant melanoma of skin). Fourth and fifth digits are assigned for the specific body site.
Don’t Forget the Body Site
In ICD-10-CM, body sites are much more specific than in ICD-9-CM and require documentation of laterality for paired organs such as eyes, ears, and upper and lower limbs. They include:
Coders must pay close attention to the body site when coding melanomas and seek to capture the most specific anatomical position possible. Especially during UV Awareness Month, the above information about coding melanomas is important for every coder to know and share.
The U.S. Court of Appeals for the Sixth Circuit has handed the False Claims Act (FCA) bar another lesson in humility – and perhaps prompted
Following the U.S. Supreme Court’s unanimous 2022 decision striking down the Centers for Medicare & Medicaid Services’ (CMS’s) differential 340B payment rates, providers faced a
Please log in to your account to comment on this article.
Sepsis remains one of the most frequently denied and contested diagnoses, creating costly revenue loss and compliance risks. In this webcast, Angela Comfort, DBA, MBA, RHIA, CDIP, CCS, CCS-P, provides practical, real-world strategies to align documentation with coding guidelines, reconcile Sepsis-2 and Sepsis-3 definitions, and apply compliant queries. You’ll learn how to identify and address documentation gaps, strengthen provider engagement, and defend diagnoses against payer scrutiny—equipping you to protect reimbursement, improve SOI/ROM capture, and reduce audit vulnerability in this high-risk area.
Only ICD10monitor delivers what you need: updates on must-know changes associated with the FY26 IPPS, including new ICD-10-CM/PCS codes, CCs/MCCs, and MS-DRGs, plus insights, analysis and answers to your questions from two of the country’s most respected subject matter experts.
This third session in our 2026 IPPS Masterclass will feature a review of FY26 changes to the MS-DRG methodology and new technology add-on payments (NTAPs), presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.
This second session in our 2026 IPPS Masterclass will feature a review the FY26 changes to ICD-10-PCS codes. This information will be presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.
During this essential RACmonitor webcast Michael Calahan, PA, MBA Certified Compliance Officer, will clarify the rules, dispel common misconceptions, and equip you with practical strategies to code, document, and bill high-risk split/shared, incident-to & critical care E/M services with confidence. Don’t let audit risks or revenue losses catch your organization off guard — learn exactly what federal auditors are looking for and how to ensure your documentation and reporting stand up to scrutiny.
Learn how to navigate the proposed elimination of the Inpatient-Only list. Gain strategies to assess admission status, avoid denials, protect compliance, and address impacts across Medicare and non-Medicare payors. Essential insights for hospitals.
RACmonitor is proud to welcome back Dr. Ronald Hirsch, one of his most requested webcasts. In this highly anticipated session, Dr. Hirsch will break down the complex Two Midnight Rule Medicare regulations, translating them into clear, actionable guidance. He’ll walk you through the basics of the rule, offer expert interpretation, and apply the rule to real-world clinical scenarios—so you leave with greater clarity, confidence, and the tools to ensure compliance.
Bring your questions and join the conversation during this open forum series, live every Wednesday at 10 a.m. EST from June 11–July 30. Hosted by Chuck Buck, these fast-paced 30-minute sessions connect you directly with top healthcare experts tackling today’s most urgent compliance and policy issues.
Prepare for the 2025 CMS IPPS Final Rule with ICD10monitor’s IPPSPalooza! Click HERE to learn more
Get 15% OFF on all educational webcasts at ICD10monitor with code JULYFOURTH24 until July 4, 2024—start learning today!
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24
